Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Signs Deal with Ariosa to Supply Array-based NIPT

NEW YORK (GenomeWeb) — Affymetrix and Ariosa Diagnostics today announced that they have signed a multi-year agreement under which Affymetrix will supply arrays and instruments for use in Ariosa's Harmony non-invasive prenatal test.

The deal "opens up the possibility to further broaden access to the Harmony test via a kit decentralization strategy," Ariosa CEO Ken Song said in a statement. Under such a strategy other laboratories would be able to run the array-based test in house.

The announcement follows the publication of an Ariosa study in Fetal Diagnosis and Therapy earlier this year, which demonstrated that array-based testing of cell-free DNA in maternal blood generated more consistent data in a shorter period of time and at a lower cost than the company's existing sequencing-based assay.

Ariosa has said it believes the lower cost of array-based NIPT will allow it to fulfill its goal of providing broader access to testing. In a release, the companies said the partnership will allow Ariosa's test to be adopted and performed by other laboratories around the world.

"We are excited about the opportunity to improve prenatal care for women globally," Song said.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.